fashion -WSS

fashion

author：comprehensive 2025-09-03 05:34:25 - browse：51688

Illustration of a prescription bottle image on the screen of a smart phone – medical tech coverage from STAT — Alex Hogan/STAT

In another sign of the business headwinds facing prescription mental health apps, developer Twill will shop around for a pharmaceutical company to market Aspiro, its cognitive behavioral therapy treatment for both generalized anxiety and major depression.

Twill executives told STAT the company hopes that a drugmaker developing or currently marketing a product for generalized anxiety, or GAD, and major depressive disorder, or MDD, will be interested in adding a digital therapeutic to boost the effect of its drug — as well as its sales. Twill’s chief strategy officer Chris Wasden said that after watching companies built around prescription digital therapeutics, or PDTs, stall out, Twill made the decision earlier this year that it would only take the product to market if it found a willing drugmaker to serve as its partner.

“A PDT is going to be more valuable in the hands of a drug company that has a drug that they would like to get greater adherence [and] greater revenues from rather than trying to get reimbursement for the PDT itself,” he said.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Health AI: on the border between health care and tech

WSS

Biden administration begins canceling student loan debt for 804,000 borrowers

Be careful with at

Senators push IRS to launch nonprofit hospital probe

Biden administration begins canceling student loan debt for 804,000 borrowers

Senators push IRS to launch nonprofit hospital probe

Health AI: on the border between health care and tech

hotspot

fashion

focus

Bright Health sells Medicare Advantage business to Molina

Novo Nordisk touts Wegovy study, but still struggling with supply

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Illinois Supreme Court finds assault weapons ban constitutional

Hepatitis C has a cure — but many Americans still lack access to it

Weight loss drugs aren’t covered by Obamacare. That may change

United colonoscopy coverage change 'may cost lives,' doctors say

A new drug could help frostbite victims avoid its ravages

Cancer drug shortages should be causing more outrage

Reporting on presidential health from Reagan to Trump and Biden

leisure time

Surge in Apellis stock fueled by confidence in safety of its eye drug

Weight loss drugs aren’t covered by Obamacare. That may change

A new drug could help frostbite victims avoid its ravages

Medicare Advantage enrollment grows 7.1% to 33.4 million people

Secretariat’s lessons for human medicine

Opioid cravings were reduced by anti

knowledge

focus

explore

focus